ROCHE FEMSTAT ONE Rx MARKETING UNDER EVALUATION; KV MAY MARKET YEAST INFECTION CREAM UNDER SEPARATE TRADE NAME; BRISTOL VAGISTAT-1 OTC TO LAUNCH IN SPRING
Executive Summary
Roche is evaluating its marketing options for Femstat One (butoconazole nitrate 2% cream) approved on Feb. 7 as a prescription one-dose treatment for vulvovaginal candidiasis.